![](/img/cover-not-exists.png)
Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States
Marc F. Botteman, Joseph Caprini, Jennifer M. Stephens, Vijay Nadipelli, Christopher F. Bell, Chris L. Pashos, Alexander T. CohenVolume:
24
Year:
2002
Language:
english
DOI:
10.1016/s0149-2918(02)80091-1
File:
PDF, 1.83 MB
english, 2002